Topical absorption and systemic toxicity

Cutaneous and Ocular Toxicology

Volumn 30, Issue 3, 2011, Pages 175-186

  Alikhan, Fatima Sasha ^a   Maibach, Howard ^b  

^a Department of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

pesticides; Systemic toxicity; topical absorption

Indexed keywords

ADAPALENE; AGENTS ACTING ON THE EYE; AMITRAZ; ARSENIC; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CHLOROACETIC ACID; CHLORPYRIFOS; CHROMIUM; CORTICOSTEROID; DIETHYLTOLUAMIDE; DIMPYLATE; GLYCERYL TRINITRATE; HYDROFLUORIC ACID; LINDANE; MERCURY; METHYL BROMIDE; MINOXIDIL; NICOTINE; PARAQUAT; PETROLEUM; PHENOL; PYRETHROID; RESORCINOL; RETINOIC ACID; SALICYLIC ACID; STRYCHNINE; SULFACETAMIDE; TRICHLOROETHYLENE; UNINDEXED DRUG;

ABDOMINAL PAIN; ADVERSE OUTCOME; APNEA; BLURRED VISION; BRADYCARDIA; CHEMOTHERAPY INDUCED EMESIS; DEPRESSION; DIARRHEA; DIZZINESS; DRY SKIN; DYSLIPIDEMIA; EMBRYOPATHY; ERYTHEMA; ERYTHEMA MULTIFORME; FATIGUE; FETUS MALFORMATION; GEOGRAPHIC PATHOLOGY; HEARING LOSS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PALPITATION; HEART RATE; HUMAN; HYPOTENSION; HYPOTHERMIA; HYPOTHYROIDISM; IMPOTENCE; LETHARGY; LUNG EDEMA; METHEMOGLOBINEMIA; MUSCLE HYPOTONIA; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; OPHTHALMIC ARTERY; PRURITUS; RETINOPATHY; REVIEW; SIDE EFFECT; SINUS ARREST; SKIN ABSORPTION; SKIN TOXICITY; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SWEATING; TACHYCARDIA; TACHYPNEA; THYROID DISEASE; TINNITUS; UNSPECIFIED SIDE EFFECT; WEAKNESS; XEROSIS;

ADMINISTRATION, TOPICAL; COSMETICS; DRUG TOXICITY; ENVIRONMENTAL POLLUTANTS; HUMANS; OCCUPATIONAL EXPOSURE; PESTICIDES; PHARMACEUTICAL PREPARATIONS; SKIN ABSORPTION;

EID: 80051529684     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.560914     Document Type: Review

References (114)

1. Freeman S, Maibach HI. Systemic toxicity caused by absorption of drugs and chemicals through the skin. In: Marzuli FN, Maibach HI, eds. Dermatotoxicology, 4th ed. New York: Hemisphere Publishing Corporation; 1991:851-875.
2. Sugihara N, Suetsugu T, Furuno K. High susceptibility to paraquatdriven lipid peroxidation of cultured hepatocytes loaded with linolenic acid. J Pharmacol Exp Ther 1995;274:187-193.
3. Sandy MS, Moldeus P, Ross D, Smith MT. Role of redox cycling and lipid peroxidation in bipyridyl herbicide cytotoxicity. Studies with a compromised isolated hepatocyte model system. Biochem Pharmacol 1986;35:3095-3101. (Pubitemid 16014705)
4. Bataller R, Bragulat E, Nogué S, Görbig MN, Bruguera M, Rodés J. Prolonged cholestasis after acute paraquat poisoning through skin absorption. Am J Gastroenterol 2000;95:1340-1343. (Pubitemid 30263535)
5. Peiró AM, Zapater P, Alenda C, Ramírez A, Gutiérrez A, Pérez- Mateo M et al. Hepatotoxicity related to paraquat and diquat absorption through intact skin. Dig Dis Sci 2007;52:3282-3284. (Pubitemid 47512492)
6. Wester RC, Maibach HI, Bucks DA, Aufrere MB. In vivo percutaneous absorption of paraquat from hand, leg, and forearm of humans. J Toxicol Environ Health 1984;14:759-762. (Pubitemid 15170058)
7. Guardascione V, Mazzella di Bosco M. [On occupational pathology caused by Paraquat, a dipyridyl herbicide]. Folia Med (Napoli) 1969;52:728-738.
8. Pateiro-Moure M, Arias-Estévez M, Simal-Gándara J. Competitive and non-competitive adsorption/desorption of paraquat, diquat and difenzoquat in vineyard-devoted soils. J Hazard Mater 2010;178:194-201.
9. Baser NT, Yalaz B, Yilmaz AC, Tuncali D, Aslan G. An unusual and serious complication of topical wart treatment with monochloroacetic acid. Int J Dermatol 2008;47:1295-1297.
10. Pirson J, Toussaint P, Segers N. An unusual cause of burn injury: Skin exposure to monochloroacetic acid. J Burn Care Rehabil 2003;24:407-409; discussion 402. (Pubitemid 37444522)
11. Berardi MR, Snyder R, Waritz RS, Cooper KR. Monochloroacetic acid toxicity in the mouse associated with blood-brain barrier damage. Fundam Appl Toxicol 1987;9:469-479.
12. Kato J, Dote T, Shimizu H, Shimbo Y, Fujihara M, Kono K. Lethal acute lung injury and hypoglycemia after subcutaneous administration of monochloroacetic acid. Toxicol Ind Health 2006;22:203-209. (Pubitemid 44081160)
13. Horowitz BZ, Albertson TE, O'Malley M, Swenson EJ. An unusual exposure to methyl bromide leading to fatality. J Toxicol Clin Toxicol 1998;36:353-357. (Pubitemid 28375840)
14. Hezemans-Boer M, Toonstra J, Meulenbelt J, Zwaveling JH, Sangster B, van Vloten WA. Skin lesions due to exposure to methyl bromide. Arch Dermatol 1988;124:917-921.
15. Zwaveling JH, de Kort WL, Meulenbelt J, Hezemans-Boer M, van Vloten WA, Sangster B. Exposure of the skin to methyl bromide: A study of six cases occupationally exposed to high concentrations during fumigation. Hum Toxicol 1987;6:491-495. (Pubitemid 18045883)
16. Yang RS, Witt KL, Alden CJ, Cockerham LG. Toxicology of methyl bromide. Rev Environ Contam Toxicol 1995;142:65-85.
17. O'Neal L. Acute methyl bromide toxicity. J Emerg Nurs 1987;13:96-98.
18. Davenport CJ, Ali SF, Miller FJ, Lipe GW, Morgan KT, Bonnefoi MS. Effect of methyl bromide on regional brain glutathione, glutathione-S-transferases, monoamines, and amino acids in F344 rats. Toxicol Appl Pharmacol 1992;112:120-127.
19. Granier R, Rambourg-Schepens MO, Muller A, Hallier E. Glutathione transferase activity and formation of macromolecular adducts in two cases of acute methyl bromide poisoning. Occup Environ Med 1996;53:211-215. (Pubitemid 26101871)
20. Lifshitz M, Gavrilov V. Central nervous system toxicity and early peripheral neuropathy following dermal exposure to methyl bromide. J Toxicol Clin Toxicol 2000;38:799-801. (Pubitemid 32047309)
21. Hayes' Handbook of Pesticide Toxicology, 3rd ed. Amsterdam: Elsevier; 2010.
22. Makarovsky I, Markel G, Hoffman A, Schein O, Brosh-Nissimov T, Tashma Z et al. Strychnine-a killer from the past. Isr Med Assoc J 2008;10:142-145.
23. Ellenhorn MJ, Barceloux DG. Medical Toxicology: Diagnosis and Treatment of Human Poisoning, 1st ed. New York: Elsevier; 1988:1086-1087.
24. Greene R, Meatherall R. Dermal exposure to strychnine. J Anal Toxicol 2001;25:344-347. (Pubitemid 32656287)
25. Sgargli GP, Mannaioni PF. Pharmacokinetics observations on a case of massive strychnine poisoning. Clin Toxicol 1973;6:533-540.
26. O'Callaghan WG, Joyce N, Counihan HE, Ward M, Lavelle P, O'Brien E. Unusual strychnine poisoning and its treatment: Report of eight cases. Br Med J (Clin Res Ed) 1982;285:478. (Pubitemid 12097651)
27. Kalyoncu M, Dilber E, Okten A. Amitraz intoxication in children in the rural Black Sea region: Analysis of forty-three patients. Hum Exp Toxicol 2002;21:269-272. (Pubitemid 34785028)
28. Atabek ME, Aydin K, Erkul I. Different clinical features of amitraz poisoning in children. Hum Exp Toxicol 2002;21:13-16. (Pubitemid 34521166)
29. Demirel Y, Yilmaz A, Gursoy S, Kaygusuz K, Mimaroglu C. Acute amitraz intoxication: Retrospective analysis of 45 cases. Hum Exp Toxicol 2006;25:613-617. (Pubitemid 44804784)
30. Aydin K, Kurtoglu S, Poyrazoglu MH, Uzüm K, Ustünbas HB, Hallaç IK. Amitraz poisoning in children: Clinical and laboratory findings of eight cases. Hum Exp Toxicol 1997;16:680-682. (Pubitemid 27514104)
31. Yaramis A, Soker M, Bilici M. Amitraz poisoning in children. Hum Exp Toxicol 2000;19:431-433. (Pubitemid 32007759)
32. Aziz SA, Knowles CO. Inhibition of monoamine oxidase by the pesticide chlordimeform and related compounds. Nature 1973;242:417-418.
33. Yim GK, Holsapple MP, Pfister WR, Hollingworth RM. Prostaglandin synthesis inhibited by formamidine pesticides. Life Sci 1978;23:2509-2515. (Pubitemid 9125920)
34. Vijverberg HP, van den Bercken J. Neurotoxicological effects and the mode of action of pyrethroid insecticides. Crit Rev Toxicol 1990;21:105-126.
35. Wilks MF. Pyrethroid-induced paresthesia-a central or local toxic effect? J Toxicol Clin Toxicol 2000;38:103-105. (Pubitemid 30212830)
36. Flannigan SA, Tucker SB, Key MM, Ross CE, Fairchild EJ 2nd, Grimes BA et al. Synthetic pyrethroid insecticides: A dermatological evaluation. Br J Ind Med 1985;42:363-372. (Pubitemid 15001012)
37. Tucker SB, Flannigan SA, Smolensky MH. Comparison of therapeutic agents for synthetic pyrethroid exposure. Contact Derm 1983;9:316. (Pubitemid 13073773)
38. Kaplan JG, Kessler J, Rosenberg N, Pack D, Schaumburg HH. Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology 1993;43:2193-2196. (Pubitemid 23346946)
39. Meggs WJ. Permanent paralysis at sites of dermal exposure to chlorpyrifos. J Toxicol Clin Toxicol 2003;41:883-886. (Pubitemid 37499020)
40. Keifer M, Mahurin R. Chronic neurological effects of pesticide exposure. Occup Med 1997;12:291-304. (Pubitemid 127791713)
41. Jamal GA. Long term neurotoxic effects of organophosphate compounds. Adverse Drug React Toxicol Rev 1995;14:85-99.
42. Dahlgren JG, Takhar HS, Ruffalo CA, Zwass M. Health effects of diazinon on a family. J Toxicol Clin Toxicol 2004;42:579-591. (Pubitemid 39281690)
43. Lur'e AA, Gleiberman SE, Tsizin IuS. [Pharmacokinetics of insect repellent, N,N-diethyltoluamide]. Med Parazitol (Mosk) 1978;47:72-77.
44. Briassoulis G, Narlioglou M, Hatzis T. Toxic encephalopathy associated with use of DEET insect repellents: A case analysis of its toxicity in children. Hum Exp Toxicol 2001;20:8-14. (Pubitemid 32372410)
45. Miller JD. Anaphylaxis associated with insect repellent. N Engl J Med 1982;307:1341-1342. (Pubitemid 12005673)
46. Clem JR, Havemann DF, Raebel MA. Insect repellent (N,Ndiethyl- m-toluamide) cardiovascular toxicity in an adult. Ann Pharmacother 1993;27:289-293. (Pubitemid 23086949)
47. Ma H. Insecticides: Chlorinated hydrocarbons, pyrethrinsm and DEET. Toxicol Emergencies 1994;5:1125.
48. Vashkov VI, Gleiberman SE, Volkova AP. [Remote effects of the use of repellents. 2. Certain problems of regulations concerning the use of diethyltoluamide (DETA)]. Med Parazitol (Mosk) 1976;45:720-725.
49. Lewis PR, Phillips TG, Sassani JW. Topical therapies for glaucoma: What family physicians need to know. Am Fam Physician 1999;59:1871-1879, 1882.
50. Goldberg I, Moloney G, McCluskey P. Topical ophthalmic medications: What potential for systemic side effects and interactions with other medications? Med J Aust 2008;189:356-357.
51. Han JA, Frishman WH, Wu Sun S, Palmiero PM, Petrillo R. Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension. Cardiol Rev 2008;16:95-108. (Pubitemid 351271699)
52. Gottfredsdottir MS, Allingham RR, Shields MB. Physicians' guide to interactions between glaucoma and systemic medications. J Glaucoma 1997;6:377-383. (Pubitemid 28051073)
53. Mabuchi F, Yoshimura K, Kashiwagi K, Shioe K, Yamagata Z, Kanba S et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma 2008;17:552-557.
54. Schuman JS. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2. Ophthalmology 2000;107:1171-1177.
55. Levy Y, Zadok D. Systemic side effects of ophthalmic drops. Clin Pediatr (Phila) 2004;43:99-101. (Pubitemid 38112273)
56. Georgala S, Befon A, Maniatopoulou E, Georgala C. Topical use of minoxidil in children and systemic side effects. Dermatology (Basel) 2007;214:101-102. (Pubitemid 46033012)
57. Ranchoff RE, Bergfeld WF. Topical minoxidil reduces blood pressure. J Am Acad Dermatol 1985;12:586-587. (Pubitemid 15144654)
58. Leenen FH, Smith DL, Unger WP. Topical minoxidil: Cardiac effects in bald man. Br J Clin Pharmacol 1988;26:481-485.
59. Satoh H, Morikaw S, Fujiwara C, Terada H, Uehara A, Ohno R. A case of acute myocardial infarction associated with topical use of minoxidil (RiUP) for treatment of baldness. Jpn Heart J 2000;41:519-523.
60. Kaler SG, Patrinos ME, Lambert GH, Myers TF, Karlman R, Anderson CL. Hypertrichosis and congenital anomalies associated with maternal use of minoxidil. Pediatrics 1987;79:434-436. (Pubitemid 17022906)
61. Smorlesi C, Caldarella A, Caramelli L, Di Lollo S, Moroni F. Topically applied minoxidil may cause fetal malformation: A case report. Birth Defects Res Part A Clin Mol Teratol 2003;67:997-1001. (Pubitemid 38018043)
62. Badii F, Maghelli S, Costa N, Borreggine D, Zoccali G, Durí D. Acute methemoglobinemia after nitroglycerine transcutaneous absorption after bomb explosion: A case report. J Trauma 2009;66:936-937.
63. Clifton J 2nd, Leikin JB. Methylene blue. Am J Ther 2003;10:289-291.
64. Welsch F. Routes and modes of administration of resorcinol and their relationship to potential manifestations of thyroid gland toxicity in animals and man. Int J Toxicol 2008;27:59-63. (Pubitemid 351302270)
65. Divi RL, Doerge DR. Mechanism-based inactivation of lactoperoxidase and thyroid peroxidase by resorcinol derivatives. Biochemistry 1994;33:9668-9674.
66. Benfeldt E, Serup J. Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: In vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Arch Dermatol Res 1999;291:517-526. (Pubitemid 29484133)
67. Maibach H, Patrick E. Dermatotoxicology. In: Hayes AW, ed. Principles and Methods of Toxicology. Philadelphia, PA: Taylor & Francis; 2001:1039-1084.
68. Pascher F. Systemic reactions to topically applied drugs. Int J Dermatol 1978;17:768-775. (Pubitemid 9101938)
69. Navarre-Belhassen C, Blanchet P, Hillaire-Buys D, Sarda P, Blayac JP. Multiple congenital malformations associated with topical tretinoin. Ann Pharmacother 1998;32:505-506. (Pubitemid 28166621)
70. Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet 1992;339:687.
71. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT et al. Retinoic acid embryopathy. N Engl J Med 1985;313:837-841. (Pubitemid 15250197)
72. Akhavan A, Bershad S. Topical acne drugs: Review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003;4:473-492. (Pubitemid 36871766)
73. Piérard GE, Piérard-Franchimont C, Paquet P, Quatresooz P. Spotlight on adapalene. Expert Opin Drug Metab Toxicol 2009;5:1565-1575.
74. Autret E, Berjot M, Jonville-Béra AP, Aubry MC, Moraine C. Anophthalmia and agenesis of optic chiasma associated with adapalene gel in early pregnancy. Lancet 1997;350:339. (Pubitemid 27351123)
75. Raschke R, Arnold-Capell PA, Richeson R, Curry SC. Refractory hypoglycemia secondary to topical salicylate intoxication. Arch Intern Med 1991;151:591-593.
76. Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhaus B et al. Significance of salicylate intolerance in diseases of the lower gastrointestinal tract. J Physiol Pharmacol 2005;56 (Suppl 5):89-102.
77. Rubin Z. Ophthalmic sulfonamide-induced Stevens-Johnson syndrome. Arch Dermatol 1977;113:235-236.
78. Davies P, Levy S, Pahari A, Martinez D. Acute nicotine poisoning associated with a traditional remedy for eczema. Arch Dis Child 2001;85:500-502. (Pubitemid 33116487)
79. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2010;12:CD006103.
80. Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol 2000;130:240-241.
81. Newell-Price J. Diagnosis/differential diagnosis of Cushing's syndrome: A review of best practice. Best Pract Res Clin Endocrinol Metab 2009;23 (Suppl 1):S5-S14.
82. Halverstam CP, Vachharajani A, Mallory SB. Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome. Pediatr Dermatol 2007;24:42-45.
83. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-1285. (Pubitemid 24333193)
84. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-257. (Pubitemid 27197964)
85. Huang H, Kamijima M, Wang H, Li S, Yoshikawa T, Lai G et al. Human herpesvirus 6 reactivation in trichloroethylene-exposed workers suffering from generalized skin disorders accompanied by hepatic dysfunction. J Occup Health 2006;48:417-423. (Pubitemid 46057873)
86. Singal A, Thami GP. Lindane neurotoxicity in childhood. Am J Ther 2006;13:277-280. (Pubitemid 44026196)
87. Bhalla M, Thami GP. Reversible neurotoxicity after an overdose of topical lindane in an infant. Pediatr Dermatol 2004;21:597-599. (Pubitemid 39363183)
88. Dollery CT. [Testing and control of therapeutic materials and drugs]. Acta Odontol Venez 1973;11:28-38.
89. Lievremont M, Barnier JV, Potus J. Gamma-hexachlorocyclohexane inhibition of the calcium fluxes at the desensitized mouse neuromuscular junction. Toxicol Appl Pharmacol 1984;76:280-287. (Pubitemid 15218207)
90. Pramanik AK, Hansen RC. Transcutaneous gamma benzene hexachloride absorption and toxicity in infants and children. Arch Dermatol 1979;115:1224-1225. (Pubitemid 10153575)
91. Ginsburg CM, Lowry W, Reisch JS. Absorption of lindane (gamma benzene hexachloride) in infants and children. J Pediatr 1977;91:998-1000. (Pubitemid 8242179)
92. Lin CC, Wu ML, Yang CC, Ger J, Tsai WJ, Deng JF. Acute severe chromium poisoning after dermal exposure to hexavalent chromium. J Chin Med Assoc 2009;72:219-221.
93. Terrill PJ, Gowar JP. Chromic acid burns; beware, be aggressive, be watchful. Br J Plast Surg 1990;43:699-701. (Pubitemid 20374063)
94. Matey P, Allison KP, Sheehan TM, Gowar JP. Chromic acid burns: Early aggressive excision is the best method to prevent systemic toxicity. J Burn Care Rehabil 2000;21:241-245. (Pubitemid 30396354)
95. Wang XW, Davies JW, Zapata Sirvent RL, Robinson WA. Chromic acid burns and acute chromium poisoning. Burns Incl Therm Inj 1985;11:181-184. (Pubitemid 15142465)
96. Asatiani N, Kartvelishvili T, Abuladze M, Asanishvili L, Sapojnikova N. Chromium (VI) can activate and impair antioxidant defense system. Biol Trace Elem Res 2010.
97. Pelclová D, Lukás E, Urban P, Preiss J, Rysavá R, Lebenhart P et al. Mercury intoxication from skin ointment containing mercuric ammonium chloride. Int Arch Occup Environ Health 2002;75 (Suppl):S54-S59. (Pubitemid 36082778)
98. Landau M. Cardiac complications in deep chemical peels. Dermatol Surg 2007;33:190-193; discussion 193. (Pubitemid 46208110)
99. Stagnone GJ, Orgel MG, Stagnone JJ. Cardiovascular effects of topical 50% trichloroacetic acid and Baker's phenol solution. J Dermatol Surg Oncol 1987;13:999-1002. (Pubitemid 17135035)
100. Botta SA, Straith RE, Goodwin HH. Cardiac arrhythmias in phenol face peeling: A suggested protocol for prevention. Aesthetic Plast Surg 1988;12:115-117.
101. Wexler MR, Halon DA, Teitelbaum A, Tadjer G, Peled IJ. The prevention of cardiac arrhythmias produced in an animal model by the topical application of a phenol preparation in common use for face peeling. Plast Reconstr Surg 1984;73:595-598. (Pubitemid 14102516)
102. Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J 2003;79:391-396. (Pubitemid 36993968)
103. Ghariani M, Adrien ML, Raucoules M, Bayle J, Jacomet Y, Grimaud D. [Subacute arsenic poisoning]. Ann Fr Anesth Reanim 1991;10:304-307.
104. Campbell JP, Alvarez JA. Acute arsenic intoxication. Am Fam Physician 1989;40:93-97. (Pubitemid 20013291)
105. Majid Cheraghali A, Haghqoo S, Shalviri G, Shariati YR, Ghassemi M, Khosravi S. Fatalities following skin exposure to arsenic. Clin Toxicol (Phila) 2007;45:965-967.
106. Turkall RM, Skowronski GA, Suh DH, Abdel-Rahman MS. Effect of a chemical mixture on dermal penetration of arsenic and nickel in male pig in vitro. J Toxicol Environ Health Part A 2003;66:647-655. (Pubitemid 36428450)
107. Wester RC, Melendres JL, Maibach HI. In vivo percutaneous absorption of acetochlor in the rhesus monkey: Dose-response and exposure risk assessment. Food Chem Toxicol 1996;34:979-983. (Pubitemid 27036780)
108. Boonyatumanond R, Murakami M, Wattayakorn G, Togo A, Takada H. Sources of polycyclic aromatic hydrocarbons (PAHs) in street dust in a tropical Asian mega-city, Bangkok, Thailand. Sci Total Environ 2007;384:420-432. (Pubitemid 47285272)
109. Kaerlev L, Hansen J, Hansen HL, Nielsen PS. Cancer incidence among Danish seafarers: A population based cohort study. Occup Environ Med 2005;62:761-765.
110. Virich G, Gudi V, Canal A. Extramammary Paget's disease- occupational exposure to used engine oil and a new skin grafting technique. J Plast Reconstr Aesthet Surg 2008;61:1528-1529.
111. Burgher F, Mathieu L, Lati E, Gasser P, Peno-Mazzarino L, Blomet J et al. Experimental 70% hydrofluoric acid burns: Histological observations in an established human skin explants ex vivo model. Cutan Ocul Toxicol 2010.
112. Kono K, Yoshida Y, Watanabe M, Tanioka Y, Dote T, Orita Y et al. An experimental study on the treatment of hydrofluoric acid burns. Arch Environ Contam Toxicol 1992;22:414-418.
113. Bartlett D. Dermal exposure to hydrofluoric acid causing significant systemic toxicity. J Emerg Nurs 2004;30:371-373. (Pubitemid 39060683)
114. Dibbell DG, Iverson RE, Jones W, Laub DR, Madison MS. Hydrofluoric acid burns of the hand. J Bone Joint Surg Am 1970;52:931-936.